|
|
Volumn 34, Issue 6, 1999, Pages 651-677
|
|
1998 IMS HEALTH hospital pharmacy review: Leading dollar volume pharmaceuticals
a
a
IQVIA
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
ALBUMIN;
ALTEPLASE;
AMOXICILLIN PLUS CLAVULANIC ACID;
AMPICILLIN;
CARBOPLATIN;
CEFTAZIDIME;
CEFTAZIDIME ARGININE;
CEFTRIAXONE;
CILASTATIN PLUS IMIPENEM;
CIPROFLOXACIN;
CLAVULANIC ACID;
DILTIAZEM;
ENOXAPARIN;
FAMOTIDINE;
FLUCONAZOLE;
FLUOXETINE;
GRANISETRON;
HUMAN ALBUMIN;
IMMUNOGLOBULIN;
IMMUNOGLOBULIN G;
IPRATROPIUM BROMIDE;
LEVOFLOXACIN;
MIDAZOLAM;
OLANZAPINE;
OMEPRAZOLE;
ONDANSETRON;
PACLITAXEL;
PAMIDRONIC ACID;
PLASMINOGEN ACTIVATOR;
POLYCYLLIN N;
PROPOFOL;
RECOMBINANT ERYTHROPOIETIN;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
SEVOFLURANE;
SULTAMICILLIN;
THYMOCYTE ANTIBODY;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
UROKINASE;
COMMERCIAL PHENOMENA;
DISEASE MANAGEMENT;
DRUG MARKETING;
ECONOMIC EVALUATION;
HEALTH CARE COST;
HOSPITAL PHARMACY;
PRESCRIPTION;
REVIEW;
UNITED STATES;
|
|
EID: 0033497786
PISSN: 00185787
EISSN: None
Source Type: Journal
DOI: 10.1177/001857879903400604 Document Type: Review |
|
Times cited : (1)
|
|
References (0)
|
